» Articles » PMID: 31181695

DDS-1 Modulates Intestinal-Specific Microbiota, Short-Chain Fatty Acid and Immunological Profiles in Aging Mice

Abstract

Distribution of the microbiota varies according to the location in the gastrointestinal (GI) tract. Thus, dysbiosis during aging may not be limited to faecal microbiota and extend to the other parts of the GI tract, especially the cecum and colon. DDS-1, a probiotic strain, has been shown to modulate faecal microbiota and its associated metabolic phenotype in aging mice. In the present study, we investigated the effect of DDS-1 supplementation on caecal- and mucosal-associated microbiota, short-chain fatty acids (SCFAs) and immunological profiles in young and aging C57BL/6J mice. Besides differences in the young and aging control groups, we observed microbial shifts in caecal and mucosal samples, leading to an alteration in SCFA levels and immune response. DDS-1 treatment increased the abundances of beneficial bacteria such as spp. and spp. more effectively in caecal samples than in mucosal samples. DDS-1 also enhanced the levels of butyrate, while downregulating the production of inflammatory cytokines (IL-6, IL-1β, IL-1α, MCP-1, MIP-1α, MIP-1β, IL-12 and IFN-γ) in serum and colonic explants. Our findings suggest distinct patterns of intestinal microbiota, improvements in SCFA and immunological profiles with DDS-1 supplementation in aging mice.

Citing Articles

Gerobiotics: Exploring the Potential and Limitations of Repurposing Probiotics in Addressing Aging Hallmarks and Chronic Diseases.

Mahamud A, Tanvir I, Kabir M, Samonty I, Chowdhury M, Rahman M Probiotics Antimicrob Proteins. 2025; .

PMID: 40029460 DOI: 10.1007/s12602-025-10501-w.


Precision Psychobiotics for Gut-Brain Axis Health: Advancing the Discovery Pipelines to Deliver Mechanistic Pathways and Proven Health Efficacy.

Slykerman R, Davies N, Vlckova K, ORiordan K, Bassett S, Dekker J Microb Biotechnol. 2025; 18(1):e70079.

PMID: 39815671 PMC: 11735468. DOI: 10.1111/1751-7915.70079.


Study the effect of ATCC 14917 for caries prevention and anti-obesity.

Yang W, Jiang M, Chen B, Jiang K, Ma N, Li Y Front Nutr. 2025; 11():1511660.

PMID: 39777074 PMC: 11703752. DOI: 10.3389/fnut.2024.1511660.


AG1, a Novel Synbiotic, Maintains Gut Barrier Function following Inflammatory Challenge in a Caco-2/THP1-Blue™ Co-Culture Model.

Sapp P, Townsend J, Kirby T, Govaert M, Duysburgh C, Verstrepen L Microorganisms. 2024; 12(7).

PMID: 39065031 PMC: 11278950. DOI: 10.3390/microorganisms12071263.


Probiotic treatment causes sex-specific neuroprotection after traumatic brain injury in mice.

Holcomb M, Marshall A, Flinn H, Lozano M, Soriano S, Gomez-Pinilla F Res Sq. 2024; .

PMID: 38645104 PMC: 11030542. DOI: 10.21203/rs.3.rs-4196801/v1.


References
1.
Biagi E, Nylund L, Candela M, Ostan R, Bucci L, Pini E . Through ageing, and beyond: gut microbiota and inflammatory status in seniors and centenarians. PLoS One. 2010; 5(5):e10667. PMC: 2871786. DOI: 10.1371/journal.pone.0010667. View

2.
Hall A, Yassour M, Sauk J, Garner A, Jiang X, Arthur T . A novel Ruminococcus gnavus clade enriched in inflammatory bowel disease patients. Genome Med. 2017; 9(1):103. PMC: 5704459. DOI: 10.1186/s13073-017-0490-5. View

3.
Beard J, Officer A, Araujo de Carvalho I, Sadana R, Pot A, Michel J . The World report on ageing and health: a policy framework for healthy ageing. Lancet. 2015; 387(10033):2145-2154. PMC: 4848186. DOI: 10.1016/S0140-6736(15)00516-4. View

4.
Gerasimov S, Ivantsiv V, Bobryk L, Tsitsura O, Dedyshin L, Guta N . Role of short-term use of L. acidophilus DDS-1 and B. lactis UABLA-12 in acute respiratory infections in children: a randomized controlled trial. Eur J Clin Nutr. 2015; 70(4):463-9. DOI: 10.1038/ejcn.2015.171. View

5.
Bier A, Braun T, Khasbab R, Segni A, Grossman E, Haberman Y . A High Salt Diet Modulates the Gut Microbiota and Short Chain Fatty Acids Production in a Salt-Sensitive Hypertension Rat Model. Nutrients. 2018; 10(9). PMC: 6164908. DOI: 10.3390/nu10091154. View